Stock listing

NASDAQ:LKFT Lakefront Biotherapeutics Stock

US listing (NASDAQ) of Lakefront Biotherapeutics · home listing Euronext:LKFT

Follow Lakefront Biotherapeutics into a list and get an email when it puts out news.

Share price · NASDAQ:LKFT

$31.82 USD +0.17 (+0.5%)

Close on Oct 27, 2026

Day range
$31.27 – $31.82 USDOct 27, 2026
Volume
170,822 sharesOct 27, 2026
Market cap
$2.08B USDAt the close on Oct 27, 2026 · price × 65.48M shares outstanding
Lakefront Biotherapeutics logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:LKFT · Home€28.92 EUR+0.02 (+0.1%)48,571€29.00€29.34€28.80€28.90Close on Oct 30, 2026
NASDAQ:LKFT$31.82 USD+0.17 (+0.5%)170,822$31.57$31.82$31.27$31.65Close on Oct 27, 2026
OTC:GLPGF$31.95 USD0.00 (0.0%)—$31.95$31.95$31.95$31.95Close on Oct 23, 2026
Frankfurt:GXE€28.64 EUR+0.32 (+1.1%)—€28.58€28.64€28.58€28.32Close on Oct 30, 2026
Frankfurt:GXEA€28.80 EUR+0.40 (+1.4%)—€28.80€28.80€28.80€28.40Close on Oct 30, 2026
Stuttgart:GXE€28.42 EUR+0.26 (+0.9%)—€28.46€28.46€28.02€28.16Close on Oct 27, 2026
Ticker
NASDAQ:LKFT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Sep 8, 2026

Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update

Aug 10, 2026

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

Jul 13, 2026

Acquisition of Own Shares

Jun 30, 2026

Lakefront Biotherapeutics NV - Acquisition of Own Shares

Jun 17, 2026

Lakefront Announces Initiation of €50 Million Stock Repurchase Program

Jun 9, 2026

Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer

Jun 8, 2026

Lakefront Receives Transparency Notification from Bank of America

May 26, 2026

Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026

Apr 28, 2026

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Mar 31, 2026

All Lakefront Biotherapeutics news

Lakefront Biotherapeutics on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 40 in all · newest Sep 8, 2026 · oldest 2025

Where Lakefront Biotherapeutics is listed

ListingExchangeCountryCurrency
Euronext:LKFT · Home listingEuronextNetherlandsEUR
NASDAQ:LKFT · This pageNASDAQUnited StatesUSD
OTC:GLPGFOTCUnited StatesUSD
EUROTLX:4LKFTEUROTLXItalyEUR
gettex:GXEgettexGermanyEUR
Lang & Schwarz:A0EAT9Lang & SchwarzGermanyEUR
Frankfurt:GXEFrankfurtGermanyEUR
Xetra:GXEXetraGermanyEUR
LSIN:0JXZLSINUnited KingdomEUR
LS Exchange:A0EAT9LS ExchangeGermanyEUR
Munich:GXEMunichGermanyEUR
Tradegate:GXETradegateGermanyEUR
B3:LKFT34B3BrazilBRL
BOATS:LKFTBOATSUnited StatesUSD
Hanover:GXEHanoverGermanyEUR
VIE:LKFTViennaAustriaEUR
Dusseldorf:GXEDusseldorfGermanyEUR
Hamburg:GXEHamburgGermanyEUR
Aquis:LKFTAAquisUnited KingdomEUR
Aquis:LKFTAAquisUnited KingdomEUR
Dusseldorf:GXEADusseldorfGermanyEUR
Frankfurt:GXEAFrankfurtGermanyEUR
gettex:GXEAgettexGermanyEUR
Lang & Schwarz:A0YGNJLang & SchwarzGermanyEUR
LS Exchange:A0YGNJLS ExchangeGermanyEUR
Stuttgart:GXEStuttgartGermanyEUR
Stuttgart:GXEAStuttgartGermanyEUR
Turquoise:LKFTATurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Lakefront Biotherapeutics.